Hypermethylation of SFRP1 and DKK1 could provide a prognostic biomarker for RCC and has been previously proposed in ccRCC (Hirata et al., 2011; Ricketts et al., 2014; Urakami et al., 2006). The gene discussed is SFRP1; the disease is renal cell carcinoma.